Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Net Income Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Net Income Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -47.84%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 23.94%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 41.36%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 44.34%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 13.84%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -27.18%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -141.44%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 38.54%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 12.92%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 38.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.87%
Mar 31, 2026 58.22%
Dec 31, 2025 36.71%
Sep 30, 2025 46.89%
Jun 30, 2025 -28.15%
Mar 31, 2025 -51.21%
Dec 31, 2024 -741.26%
Sep 30, 2024 -113.80%
Jun 30, 2024 -167.77%
Mar 31, 2024 95.97%
Dec 31, 2023 91.80%
Sep 30, 2023 59.54%
Jun 30, 2023 81.34%
Mar 31, 2023 -1,108.37%
Dec 31, 2022 7.42%
Sep 30, 2022 -10.82%
Jun 30, 2022 -60.94%
Mar 31, 2022 24.06%
Dec 31, 2021 15.56%
Sep 30, 2021 44.75%